• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过脂质体包封提高更昔洛韦和膦甲酸钠在体外抑制巨细胞病毒复制的效力。

Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.

作者信息

Bakker-Woudenberg I A, Lokerse A F, ten Kate M

机构信息

Department of Clinical Microbiology, Erasmus University Rotterdam, The Netherlands.

出版信息

Scand J Infect Dis Suppl. 1990;74:54-7.

PMID:1965866
Abstract

The antiviral effect of ganciclovir and foscarnet encapsulated in liposomes was studied against cytomegalovirus in human embryonic lung fibroblast cells. Substantially greater activity (3.5-fold and 38-fold respectively) in terms of inhibition of virus replication intracellularly was found compared to that seen with non-encapsulated antiviral agents, and liposome encapsulation did not result in increased cytotoxicity.

摘要

研究了脂质体包裹的更昔洛韦和膦甲酸钠对人胚肺成纤维细胞中巨细胞病毒的抗病毒作用。与未包裹的抗病毒药物相比,在细胞内抑制病毒复制方面发现活性显著更高(分别为3.5倍和38倍),且脂质体包裹并未导致细胞毒性增加。

相似文献

1
Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.通过脂质体包封提高更昔洛韦和膦甲酸钠在体外抑制巨细胞病毒复制的效力。
Scand J Infect Dis Suppl. 1990;74:54-7.
2
[In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].[巨细胞病毒对更昔洛韦和膦甲酸的体外敏感性]
Rev Esp Quimioter. 2001 Jun;14(2):155-64.
3
Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.更昔洛韦与膦甲酸钠联合使用在体外和体内对巨细胞病毒和2型单纯疱疹病毒的疗效增强。
Antiviral Res. 1989 Nov;12(4):205-12. doi: 10.1016/0166-3542(89)90030-2.
4
Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.脂质体制剂中更昔洛韦新型抗病毒脂质前药的玻璃体内毒理学及疗效持续时间
Invest Ophthalmol Vis Sci. 2000 May;41(6):1523-32.
5
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.更昔洛韦与膦甲酸钠对巨细胞病毒体外复制的协同作用。
Antimicrob Agents Chemother. 1990 Feb;34(2):373-5. doi: 10.1128/AAC.34.2.373.
6
In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet.
Ger J Ophthalmol. 1994 Jan;3(1):5-8.
7
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
Lancet. 1991 May 25;337(8752):1292-3. doi: 10.1016/0140-6736(91)92965-5.
8
Problems in the management of cytomegalovirus infection in patients with AIDS.
Int J STD AIDS. 1991 Nov-Dec;2(6):405-10. doi: 10.1177/095646249100200602.
9
Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.长效循环脂质体包裹的更昔洛韦可增强单纯疱疹病毒胸苷激酶自杀基因疗法的疗效。
J Control Release. 2007 Jul 16;120(1-2):104-10. doi: 10.1016/j.jconrel.2007.04.011. Epub 2007 Apr 21.
10
Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.通过脂质体包封增强膦甲酸和膦乙酸对单纯疱疹病毒2型复制的抑制效果。
Antimicrob Agents Chemother. 1988 Jun;32(6):858-64. doi: 10.1128/AAC.32.6.858.

引用本文的文献

1
Minimising the dosage-limiting toxicities of foscarnet induction therapy.尽量减少膦甲酸诱导疗法的剂量限制性毒性。
Drug Saf. 1997 Apr;16(4):258-66. doi: 10.2165/00002018-199716040-00003.
2
Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.膦甲酸钠的脂质体包封可防止游离膦甲酸钠引起的低钙血症。
Antimicrob Agents Chemother. 1995 Sep;39(9):1973-8. doi: 10.1128/AAC.39.9.1973.
3
Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.脂质体作为抗菌剂或免疫调节剂的载体用于感染治疗。
Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S61-7. doi: 10.1007/BF02389881.
4
Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.更昔洛韦。其在巨细胞病毒感染中治疗应用的最新情况。
Drugs. 1994 Sep;48(3):455-84. doi: 10.2165/00003495-199448030-00009.